Wang, B., Wang, G., Wu, G., Li, Q., Xu, Y., Ji, F., & Xu, Z. (2018). Downregulation of serum miR-101 is associated with worse prognosis in non-small cell lung cancer. Int J Clin Exp Pathol.

Wang, Bin, Guansong Wang, Guoming Wu, Qi Li, Yu Xu, Fuyun Ji, και Zhi Xu. "Downregulation of Serum MiR-101 Is Associated With Worse Prognosis in Non-small Cell Lung Cancer." Int J Clin Exp Pathol 2018.

Wang, Bin, et al. "Downregulation of Serum MiR-101 Is Associated With Worse Prognosis in Non-small Cell Lung Cancer." Int J Clin Exp Pathol 2018.